ArticleInternational journal of breast cancer2026

Impact of Adjuvant Chemotherapy on Survival Outcomes in Intermediate- and High-Risk ER+/HER2- Breast Cancer Stratified by Genomic Profiling: A Meta-Analysis.

Max Seabrook et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.